ArticleBMC pharmacology & toxicology2025
Green synthesis, characterization and antibacterial potential of zinc oxide nanoparticles with naringenin.
Article in BMC pharmacology & toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Eco-friendly synthesis of zinc oxide nanoparticlesRSC advances · 2026Article
- Sustainable nanomaterials for precision dental medicine: green synthesis, therapeutic applications, and future directions.Journal of nanobiotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In comparison to physical and chemical fabrication of metal nanoparticles, green synthesized nanoparticles are non-toxic, biocompatible, and biodegradable; they undergo a single-step bioreduction process. This research was primarily driven by the goal of creating an environment friendly, efficient, and sustainable process for synthesizing ZnO NPs using naringenin, a naturally occurring flavonoid with well-established medicinal benefits. The growing need to replace traditional chemical synthesis methods which frequently involve energy-intensive processes and toxic reducing agents with environment friendly, biocompatible, and scalable alternatives served as the impetus for the study. The synthesized ZnO NPs were characterized using different analytical techniques such as UV-Vis, FTIR, XRD, FESEM-EDS and HRTEM. The UV-Vis spectra of the synthesized zinc oxide nanoparticles showed a strong absorption peak at 374 nm. The XRD pattern exhibits prominent and precise diffraction, which indicate good crystallinity. Both FESEM and HRTEM confirmed that the synthesized ZnO NPs were compactly organized and polycrystalline-looking particles with an average size 25 to 31 nm. EDS analysis provided further evidence of the product’s purity. Disc diffusion method was used to examined the antibacterial potential of the synthesized ZnO NPs against pathogenic bacterial strains namely S. aureus, P. aeruginosa, K. pneumoniae, and E. faecalis. The zones of inhibition of 11 ± 0.1 mm, 10 ± 0.1 mm, 9 ± 0.1 mm and 9 ± 0.1 mm was observed in E. faecalis, K. pneumoniae, P. aeruginosa, and S. aureus respectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.